BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pantazopoulos IN, Troupis GT, Pantazopoulos CN, Xanthos TT. Nifekalant in the treatment of life-threatening ventricular tachyarrhythmias. World J Cardiol 2011; 3(6): 169-176 [PMID: 21772943 DOI: 10.4330/wjc.v3.i6.169]
URL: https://www.wjgnet.com/1949-8462/full/v3/i6/169.htm
Number Citing Articles
1
Yan Wang. Fulminant Myocarditis2022; : 251 doi: 10.1007/978-981-19-5759-8_16
2
Frank Zoerner, Egidijus Semenas. Resuscitation with amiodarone increases survival after hemorrhage and ventricular fibrillation in pigsJournal of Trauma and Acute Care Surgery 2014; 76(6): 1402 doi: 10.1097/TA.0000000000000243
3
Juanjuan Jiang, Li Xu, Lin Chai, Li Zhang, Hong Liu, Yan Yan, Xiaoyuan Guan, Hui Sun, Lei Tian. Population pharmacokinetic/pharmacodynamic modeling of nifekalant injection with varies dosing plan in Chinese volunteers: a randomized, blind, placebo-controlled studyJournal of Pharmacokinetics and Pharmacodynamics 2024; 51(1): 77 doi: 10.1007/s10928-023-09882-8
4
G. KARLIS, N. IACOVIDOU, P. LELOVAS, P. NIFOROPOULOU, A. ZACHARIOUDAKI, A. PAPALOIS, K. SUNDE, P. A. STEEN, T. XANTHOS. Effects of early amiodarone administration during and immediately after cardiopulmonary resuscitation in a swine modelActa Anaesthesiologica Scandinavica 2014; 58(1): 114 doi: 10.1111/aas.12226
5
Jiashan Zhang, Ying Zan, Hua Huo, Yanfang Liu, Yunbiao Tang, Yaling Han. Population pharmacokinetic/pharmacodynamic modelling of nifekalant in healthy Chinese volunteersEuropean Journal of Pharmaceutical Sciences 2020; 151: 105385 doi: 10.1016/j.ejps.2020.105385
6
Takashi Tagami, Hideo Yasunaga, Hiroyuki Yokota. Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillationCritical Care 2017; 21(1) doi: 10.1186/s13054-017-1639-8
7
T. Tagami, H. Yasunaga, H. Yokota. Annual Update in Intensive Care and Emergency Medicine 2017Annual Update in Intensive Care and Emergency Medicine 2017; : 213 doi: 10.1007/978-3-319-51908-1_18
8
Brit Long, Alex Koyfman. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular TachycardiaThe Journal of Emergency Medicine 2017; 52(4): 484 doi: 10.1016/j.jemermed.2016.09.010
9
George Karlis, Nicoletta Iacovidou, Pavlos Lelovas, Panagiota Niforopoulou, Apostolos Papalois, Ioanna Siafaka, Spyros Mentzelopoulos, Theodoros Xanthos. Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular FibrillationCardiovascular Drugs and Therapy 2015; 29(5): 425 doi: 10.1007/s10557-015-6604-7
10
Takashi Tagami, Hiroki Matsui, Saori Ishinokami, Masao Oyanagi, Akiko Kitahashi, Reo Fukuda, Kyoko Unemoto, Kiyohide Fushimi, Hideo Yasunaga. Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrestResuscitation 2016; 109: 127 doi: 10.1016/j.resuscitation.2016.08.017
11
Aiyana M. Emigh Cortez, Kevin R. DeMarco, Kazuharu Furutani, Slava Bekker, Jon T. Sack, Heike Wulff, Colleen E. Clancy, Igor Vorobyov, Vladimir Yarov-Yarovoy. Structural modeling of hERG channel–drug interactions using RosettaFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1244166
12
George Karlis, Sevasti Afantenou. Drugs in cardiac arrest: the rise and fall of antiarrhythmicsActa Cardiologica 2018; 73(4): 325 doi: 10.1080/00015385.2017.1389803
13
Yukio Hayashi, Mika Sakai, Yosuke Tachibana, Emiri Saiki, Yuka Miyata. Pharmacological cardioversion by nifekalant after release of the aortic cross‐clamp during cardiac surgeryAnaesthesia Cases 2018; 6(2): 25 doi: 10.21466/ac.PCBNARO.2018
14
Ageliki Laina, George Karlis, Aris Liakos, Georgios Georgiopoulos, Dimitrios Oikonomou, Evangelia Kouskouni, Athanasios Chalkias, Theodoros Xanthos. Amiodarone and cardiac arrest: Systematic review and meta-analysisInternational Journal of Cardiology 2016; 221: 780 doi: 10.1016/j.ijcard.2016.07.138